Skip to content

Endogenous Lithium Clearance in Acute Kidney Injury

Endogenous Lithium Clearance in Acute Kidney Injury

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05982340
Enrollment
20
Registered
2023-08-08
Start date
2023-08-01
Completion date
2025-05-20
Last updated
2025-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury Due to Sepsis, Lithium Clearance, Proximal Tubule Function

Brief summary

Critically ill patients are at high risk of developing acute kidney injury (AKI). Lithium is freely filtrated at the glomerulus and almost completely reabsorbed in the proximal tubule, which provides a quantitative estimation of proximal tubule reabsorption. The investigators hypothesized that endogenous lithium reabsorption is impaired in the early stages of critical illness. Investigators would like to study 10 ICU patients with AKI diagnosed, 10 patients without AKI, and 10 healthy controls.

Detailed description

Blood and urine samples will be obtained at 08:00, 14:00 and 20:00 during one day. Renal clearance of creatinine (CCr) and lithium will be calculated.

Interventions

DIAGNOSTIC_TESTLithium clearance

Blood and urine samples

Sponsors

University Hospital of North Norway
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* ICU patients diagnosed with AKI, without AKI and healthy controls

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Renal lithium clearance2 daysClearance of lithium from the body

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026